A

Agile Therapeutics Inc
OTC:AGRX

Watchlist Manager
Agile Therapeutics Inc
OTC:AGRX
Watchlist
Price: 0.6022 USD Market Closed
Market Cap: $10.4m

Operating Margin

-87.2%
Current
Improving
by 135.6%
vs 3-y average of -222.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-87.2%
=
Operating Income
$-15.9m
/
Revenue
$21.5m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-87.2%
=
Operating Income
$-15.9m
/
Revenue
$21.5m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Agile Therapeutics Inc
F:0AL
9.3m EUR
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
223.2B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
FR
Sanofi SA
PAR:SAN
97.1B EUR
Loading...

Market Distribution

Lower than 84% of companies in the United States of America
Percentile
16th
Based on 14 112 companies
16th percentile
-74.2%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Agile Therapeutics Inc
Glance View

Market Cap
10.4m USD
Industry
Pharmaceuticals

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. The company is headquartered in Princeton, New Jersey and currently employs 30 full-time employees. The company went IPO on 2014-05-22. The Company’s sole approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive. Twirla is a method of contraception for use in women of reproductive potential for whom a combined hormonal contraceptive is appropriate. Twirla is a prescription combined hormonal contraceptive patch, which contains the active ingredients ethinyl estradiol (EE), which is a synthetic estrogen and levonorgestrel (LNG), which is a type of progestin. Twirla delivers 30 micrograms of EE per day, a dose of EE consistent with the dose delivered by many commonly prescribed oral contraceptives. The firm commercializes Twirla in the United States. Twirla leverages the Company’s transdermal patch technology called Skinfusion. Skinfusion is designed to allow drug delivery through the skin while optimizing patch adhesion and patient comfort and wearability.

AGRX Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-87.2%
=
Operating Income
$-15.9m
/
Revenue
$21.5m
What is Agile Therapeutics Inc's current Operating Margin?

The current Operating Margin for Agile Therapeutics Inc is -87.2%, which is above its 3-year median of -222.8%.

How has Operating Margin changed over time?

Over the last 3 years, Agile Therapeutics Inc’s Operating Margin has increased from -7 775.2% to -87.2%. During this period, it reached a low of -7 775.2% on Mar 3, 2021 and a high of -80.1% on May 1, 2024.

Back to Top